Browsing “July, 2020 | EVERSANA”

EVERSANA™ and Havas Health & You announce exclusive strategic partnership, optimizing global data & analytics platform, expansive network reach and commercialization expertise for life sciences category

CHICAGO – July 30, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and […]

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO, Illinois – July 29, 2020 – Vineti, the California-based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commercial services to the life science […]

Trump Signs 4 Executive Orders on Prescription Drug Pricing

Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #apo #generics #gqce #procurement #vbp #volumebasedprocurement PRICENTRIC BRIEF: United States President Donald Trump has signed four Executive Orders on prescription drug pricing that (1) pass on savings for insulins and epinephrine through the 340B program to patients, (2) end kickbacks, (3) allow the importation of certain prescription drugs, as well as re-importation of insulin, and (4) make […]

China’s 3rd Round of Volume-Based Procurement Includes 56 Drugs, 86 Product Specifications

Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #apo #generics #gqce #procurement #vbp #volumebasedprocurement PRICENTRIC BRIEF: The Allied Purchase Office (APO) has announced that it is starting to collect essential data on the proposed list of products for China’s third go at national volume-based procurement (VBP) of medicines This list includes 56 drugs by generic name with 86 product specifications China first trialed volume-based […]

EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments

CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. ICER is an independent nonprofit […]

Germany’s AOK Opens Tender to Secure 119 APIs Worth 2 Billion Euros Per Year

Region: EUROPE | Type: Tender | Keywords: #aok #drugdiscountcontract #drugsupply #healthfund PRICENTRIC BRIEF: The largest statutory health fund of Germany covering 30% of the total population, AOK has launched a tender for nationwide drug discount contracts that is comprised of 120 lots with a total of 119 active pharmaceutical ingredients (APIs) The contract will last from June 1, 2021 until May 31, 2023, with […]

ASEAN Joint Assessment Procedure Prioritizes 11 Diseases

Region: ASIA & SOUTH PACIFIC | Type: HTA | Keywords: #access #aids #asean #breastcancer #chronicillnesses #depression #drugapprovals #hiv #jointassessment #lungcancer #nationalmedicinesregulatoryauthorities #nra #oncology #regulation PRICENTRIC BRIEF: The National Medicines Regulatory Authorities (NRA) of the Association of Southeast Asian Nations (ASEAN) has developed a new procedure for joint marketing authorizations, the ASEAN Joint Assessment Procedure Now that the pilot, which was kicked off in July 2017 and advised technically by the World […]

Pharma No Longer Allowed Annual Price Increases for Certain Medicines in Pakistan

Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #annualpricehikes #drap #drugpricingpolicy #nationalhealthservice #priceincreases PRICENTRIC BRIEF: The Drug Pricing Policy, 2018 has been revised by the federal government to allow the government to prevent pharmaceutical companies from annual price increases for a category of drugs, announced the Ministry of National Health Services Previously under the Drug Pricing Policy, 2018, pharmaceutical companies were granted […]

EVERSANA™ adds powerful predictive analytics platform with HVH Precision Analytics acquisition

Strengthens integrated commercial services with RWD and AI/ML Platform CHICAGO – July 15, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, and leveraging analytic expertise originally honed […]

Australian Biosimilars Association Hosts Successful Awareness Week, Plans Webinar

Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #awareness #biosimilars #education #gbma #webinar PRICENTRIC BRIEF: In May, GBMA Education, the educational arm of Australia’s Generic and Biosimilar Medicines Association (GBMA), hosted its second Biosimilar Awareness Week, which included online activities and the dissemination of online information to over 540,000 Australians on biosimilars and their crucial role “in the future of a sustainable healthcare […]